{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:07:46Z","timestamp":1753888066113,"version":"3.41.2"},"reference-count":25,"publisher":"FapUNIFESP (SciELO)","issue":"5","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"DOI":"10.1590\/1806-9282.20221163","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:59:16Z","timestamp":1684504756000},"source":"Crossref","is-referenced-by-count":0,"title":["Effects of hepatitis C virus genotypes and viral load on glucose and lipid metabolism after sustained virological response with direct-acting antivirals"],"prefix":"10.1590","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-2957","authenticated-orcid":false,"given":"Juc\u00e9li M\u00e1rcia Hendges","family":"Sparvoli","sequence":"first","affiliation":[{"name":"Universidade Federal do Rio Grande,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9885-0454","authenticated-orcid":false,"given":"Antonio Cardoso","family":"Sparvoli","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1227-5613","authenticated-orcid":false,"given":"Afonso Alexandre","family":"Pereira","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6379-0343","authenticated-orcid":false,"given":"Ana Luisa Machado de","family":"Paula","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6956-2405","authenticated-orcid":false,"given":"La\u00eds","family":"Garcia","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6580-6417","authenticated-orcid":false,"given":"Carla Vitola","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6095097","DOI":"10.1155\/2018\/6095097","article-title":"Glucose metabolism changes in patients with chronic hepatitis C treated with direct acting antivirals","volume":"2018","author":"Drazilova S","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.27424","article-title":"Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients","volume":"61","author":"Meissner EG","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3748\/wjg.v22.i4.1461","article-title":"Metabolic alterations and hepatitis C: from bench to bedside","volume":"22","author":"Chang ML","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/gut.2010.236158","article-title":"Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2\/3","volume":"61","author":"Thompson AJ","year":"2012","journal-title":"Gut"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1590\/S1415-790X2004000400010","article-title":"Hepatites virais: aspectos da epidemiologia e da preven\u00e7\u00e3o","volume":"7","author":"Ferreira CT","year":"2004","journal-title":"Rev Bras Epidemiol"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1478-3231.2007.01626.x","article-title":"High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C","volume":"28","author":"Hsu CS","year":"2008","journal-title":"Liver Int"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1365-2036.2009.04094.x","article-title":"Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study","volume":"30","author":"Tsochatzis E","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2337\/dc07-0358","article-title":"Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women\u2019s Health Initiative Observational Study","volume":"30","author":"Song Y","year":"2007","journal-title":"Diabetes Care"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","article-title":"TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study","volume":"93","author":"Vasques AC","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"ref10","first-page":"178","article-title":"Diretrizes da sociedade Brasileira de diabetes 2019-2020","volume":"8","year":"2019","journal-title":"Alamedas"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2337\/dc17-0485","article-title":"Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus","volume":"40","author":"Hum J","year":"2017","journal-title":"Diabetes Care"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/apt.15102","article-title":"Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetes","volume":"49","author":"Li J","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2019.1653184","article-title":"HCV treatment with direct acting antivirals improves the insulin sensitivity","volume":"17","author":"Alsebaey A","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"ref14","first-page":"139","article-title":"Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: a cohort study","volume":"42","author":"Lanini S","year":"2019","journal-title":"New Microbiol"},{"key":"ref15","first-page":"1","article-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","year":"2018","journal-title":"Secr Vigil\u00e2ncia em Sa\u00fade Dep DST, Aids e Hepatites Virais"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews DR","year":"1985","journal-title":"Diabetologia"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2018-316234","article-title":"Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis","volume":"67","author":"Cacoub P","year":"2018","journal-title":"Gut"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/jmv.24954","article-title":"Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents","volume":"90","author":"Ciancio A","year":"2018","journal-title":"J Med Virol"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4172\/2155-6156.1000766","article-title":"The effect of hepatitis c virus eradication with new direct acting antivirals on glucose homeostasis in non-diabetic Egyptian patients","volume":"8","author":"Shehab Eldin W","year":"2017","journal-title":"J Diabetes Metab"},{"issue":"2","key":"ref20","first-page":"531","article-title":"Prediabetes and intermediate hyperglycemia prevalence in adults and associated factors, Health National Survey","volume":"26","author":"Iser BPM","year":"2021","journal-title":"Cien Saude Colet"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cld.2017.03.004","article-title":"Metabolic manifestations of hepatitis c virus: diabetes mellitus, dyslipidemia","volume":"21","author":"Serfaty L","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"35","key":"ref22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4254\/wjh.v8.i35.1557","article-title":"Hepatitis C eradication with sofosbuvir leads to significant metabolic changes","volume":"8","author":"Morales AL","year":"2016","journal-title":"World J Hepatol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/cells8030252","article-title":"Hepatitis C direct acting antivirals and ribavirin modify lipid but not glucose parameters","volume":"8","author":"Doyle MA","year":"2019","journal-title":"Cells"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12664-019-00935-w","article-title":"Effect of sofosbuvir and daclatasvir on lipid profile, glycemic control and quality of life index in chronic hepatitis C, genotype 3 patients","volume":"38","author":"Jain A","year":"2019","journal-title":"Indian J Gastroenterol"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kjms.2017.07.003","article-title":"The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agents","volume":"33","author":"Huang JF","year":"2017","journal-title":"Kaohsiung J Med Sci"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302023000500606&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T13:59:39Z","timestamp":1684504779000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302023000500606&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023]]}},"alternative-id":["S0104-42302023000500606"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20221163","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"type":"electronic","value":"1806-9282"},{"type":"print","value":"0104-4230"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e20221163"}}